Price $47.60 |
Market Cap
804.3M
|
Sector Health Care |
Div. Growth
16.10%
|
|
P/E
44.1
|
P/B
5.1
|
P/S
6.72
|
Dividend %
0.90%
|
|
P/CF
47.1
|
P/FCF
53.1
|
Op. Cash Flow
26.2K
|
FCF
0.7
|
|
Op. Margin
19.90%
|
Net Margin
15.40%
|
ROE
12.30%
|
ROI
11.80%
|
|
ROA
8.40%
|
EPS Growth
-5.10%
|
Current Ratio
4.4
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Community Health Systems Inc (CYH) | $10.92 | - | - | 884M | Strong Buy |
| Harrow Health Inc (HROW) | $8.71 | - | - | 159.6M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $4.62 | - | - | 166.4M | Strong Buy |
| China Pharma Holdings, Inc. (CPHI) | $0.75 | - | - | 19.8M | Strong Buy |
| STRATA Skin Sciences Inc (SSKN) | $1.78 | - | - | 50.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
